AngioDynamics sales, earnings climb

Interventional technology developer AngioDynamics reported 2005 fiscal second-quarter net sales of $14.4 million, up 22% compared to the $11.9 million booked in the second quarter a year ago.

For the period (end-November 27), the Queensbury, NY-based E-Z-EM spin-off had net earnings of $1 million, compared to net earnings of $600,000 last year. AngioDynamics attributed the sales gains to strong growth from new products, as well as continued market-share gains across its entire product portfolio.

By staff writers
December 21, 2004

Related Reading

E-Z-EM posts strong Q1, October 8, 2004

Berlex, Bracco, E-Z-EM, PETNet form consortium, September 27, 2004

E-Z-EM completes AngioDynamics spin-off, August 20, 2004

E-Z-EM debuts VoLumen, August 10, 2004

AngioDynamics gives new name to laser venous system, August 6, 2004

Copyright © 2004

Page 1 of 180
Next Page